R01 CA112029/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	5
2007	1
2008	8
2009	10
2010	5
2011	3
2012	9
2013	11
2014	8
2015	7
2016	2
2024	0

1

NFAT as cancer target: mission possible?

Qin JJ, Nag S, Wang W, Zhou J, Zhang WD, Wang H, Zhang R. Qin JJ, et al. Biochim Biophys Acta. 2014 Dec;1846(2):297-311. doi: 10.1016/j.bbcan.2014.07.009. Epub 2014 Jul 26. Biochim Biophys Acta. 2014. PMID: 25072963 Free PMC article. Review.

2

MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Yao HP, Zhou YQ, Zhang R, Wang MH. Yao HP, et al. Nat Rev Cancer. 2013 Jul;13(7):466-81. doi: 10.1038/nrc3545. Nat Rev Cancer. 2013. PMID: 23792360 Review.

3

Targeting MDM2-p53 interaction for cancer therapy: are we there yet?

Nag S, Zhang X, Srivenugopal KS, Wang MH, Wang W, Zhang R. Nag S, et al. Curr Med Chem. 2014;21(5):553-74. doi: 10.2174/09298673113206660325. Curr Med Chem. 2014. PMID: 24180275 Free PMC article. Review.

4

Oncogenes as novel targets for cancer therapy (part III): transcription factors.

Zhang Z, Li M, Rayburn ER, Hill DL, Zhang R, Wang H. Zhang Z, et al. Am J Pharmacogenomics. 2005;5(5):327-38. doi: 10.2165/00129785-200505050-00005. Am J Pharmacogenomics. 2005. PMID: 16196502 Review.

5

Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Wang W, Qin JJ, Voruganti S, Nag S, Zhou J, Zhang R. Wang W, et al. Med Res Rev. 2015 Nov;35(6):1220-67. doi: 10.1002/med.21358. Epub 2015 Jul 30. Med Res Rev. 2015. PMID: 26227500 Free PMC article. Review.

6

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Wang W, Nag S, Zhang X, Wang MH, Wang H, Zhou J, Zhang R. Wang W, et al. Med Res Rev. 2015 Mar;35(2):225-85. doi: 10.1002/med.21327. Epub 2014 Aug 28. Med Res Rev. 2015. PMID: 25164622 Free PMC article. Review.

7

miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.

Qian B, Nag SA, Su Y, Voruganti S, Qin JJ, Zhang R, Cho WC. Qian B, et al. Curr Cancer Drug Targets. 2013 Jun;13(5):519-41. doi: 10.2174/15680096113139990031. Curr Cancer Drug Targets. 2013. PMID: 23597193 Review.

8

Targeting the NFκB signaling pathways for breast cancer prevention and therapy.

Wang W, Nag SA, Zhang R. Wang W, et al. Curr Med Chem. 2015;22(2):264-89. doi: 10.2174/0929867321666141106124315. Curr Med Chem. 2015. PMID: 25386819 Free PMC article. Review.

9

The MDM2-p53 pathway revisited.

Nag S, Qin J, Srivenugopal KS, Wang M, Zhang R. Nag S, et al. J Biomed Res. 2013 Jul;27(4):254-71. doi: 10.7555/JBR.27.20130030. Epub 2013 Jun 6. J Biomed Res. 2013. PMID: 23885265 Free PMC article.

10

Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?

Rayburn ER, Zhang R. Rayburn ER, et al. Drug Discov Today. 2008 Jun;13(11-12):513-21. doi: 10.1016/j.drudis.2008.03.014. Epub 2008 May 3. Drug Discov Today. 2008. PMID: 18549978 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year